ArticleClinical and experimental vaccine research2022
Preparation and field study of combined vaccine against
Article in Clinical and experimental vaccine research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 4 citations in OpenAlex.
- Type A and DFrontiers in cellular and infection microbiology · 2026Article
- Seroprevalence of bovine viral diarrhea in Camelus dromedarius from Tunisia.Tropical animal health and production · 2025Article
- A lipid nanoparticle encapsulated CPA-CTD mRNA vaccine provides protection againstFrontiers in immunology · 2025Article
- Sudden death due to enterotoxemia among Arabian camels (Open veterinary journal · 2024Article
- A Novel Multiepitope Fusion Antigen as a Vaccine Candidate for the Prevention of EnterotoxigenicVaccines · 2024Article
- Camel viral diseases: Current diagnostic, therapeutic, and preventive strategies.Frontiers in veterinary science · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe key objective of this study was to formulate a local combined inactivated gel adjuvanted vaccine containing bovine viral diarrhea virus (BVDV)-1, BVDV-2 viruses and MATERIALS AND
methodsThe local BVDV cytopathic strains and a local strain of toxigenic
resultsBoth monovalent (vaccine A) and combined vaccines (vaccine C) showed a protective level (4.5 and 3 IU/mL, respectively) against
conclusionVaccination of camels with the combined vaccine adjuvanted by Montanide gel containing
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.